Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

PRVA stock hub

Privia Health Group, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PRVAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.9B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PRVA

In the news

Latest news · PRVA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E74.8

P25 12.6P50 18.3P75 33.7

Trailing P/E136

P25 15P50 23.3P75 38.5

ROE3.6

P25 -106.6P50 -46.9P75 -3.1

ROIC6.2

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PRVA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

254

Groups with data

Currency

USD

Showing 254 of 254 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001759655
Company name	Privia Health Group, Inc.
Country	United States
Country code	US
Cusip	74276R102
Employees	1,226
Employees Change	86%
Employees Change Percent	7.54
Enterprise value	$2.5B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Health Information Services
IPO Date	2021-04-29
Isin	US74276R1023
Last refreshed	2026-05-10
Market cap	$2.9B
Market cap category	Mid-Cap
Price	$23.06
Price currency	USD
Rev Per Employee	1,832,456.77x
Sector	Healthcare
Sic	8000
Symbol	PRVA
Website	https://www.priviahealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.75%
EV Earnings	114.66x
EV Sales Forward	0.98x
EV/EBIT	68.48x
EV/EBITDA	52.28x
EV/FCF	18.08x
EV/Sales	1.11x
FCF yield	4.75%
Forward P/E	74.8x
P/B ratio	3.85x
P/E ratio	136.01x
P/S ratio	1.29x
PE Ratio3 Y	137.32x
PE Ratio5 Y	141.79x
PEG ratio	1.57x
PS Forward	1.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.62%
EBITDA Margin	2.12%
FCF margin	6.14%
Gross margin	9.97%
Gross Profit	$224M
Gross Profit Growth	23.22%
Gross Profit Growth Q	31.79%
Gross Profit Growth3 Y	15.94%
Gross Profit Growth5 Y	20.59%
Net Income	$21.8M
Net Income Growth	39.32%
Net Income Growth Q	-27.39%
Net Income Growth Years	1%
Net Income Growth3 Y	10.23%
Net Income Growth5 Y	-6.97%
Pretax Margin	2.01%
Profit Margin	0.97%
Profit Per Employee	$17,751
Profitable Years	3
ROA	1.75
Roa5y	-4.85
ROCE	4.46
ROE	3.61
Roe5y	-11.26
ROIC	6.18
Roic5y	-30.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-1.12%
Cagr3y	-7.45%
Cagr5y	-6.62%
EPS Growth	41.34
EPS Growth Q	-33.33
EPS Growth Years	1
EPS Growth3 Y	6.98
EPS Growth5 Y	-12.03
FCF Growth	16.6%
FCF Growth3 Y	52.3%
FCF Growth5 Y	26.19%
OCF Growth	16.6%
OCF Growth3 Y	52.21%
OCF Growth5 Y	25.98%
Revenue Growth	24.72x
Revenue Growth Q	25.78x
Revenue Growth Quarters	21x
Revenue Growth Years	7x
Revenue Growth3 Y	16.27x
Revenue Growth5 Y	22.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.73
Assets	$1.4B
Cash	$419.5M
Current Assets	$966M
Current Liabilities	$601.3M
Debt	$9M
Debt EBITDA	$0.18
Debt Equity	$0.01
Debt FCF	$0.07
Equity	$805.9M
Liabilities	$612M
Long Term Assets	$451.9M
Long Term Liabilities	$10.7M
Net Cash	$410.5M
Net Cash By Market Cap	$14.13
Net Cash Growth	-11.51%
Net Debt EBITDA	$-8.6
Net Debt Equity	$-0.51
Net Debt FCF	$-2.97
Tangible Book Value	$330.4M
Tangible Book Value Per Share	$2.63
WACC	9.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.61
Net Working Capital	$-52.7M
Quick ratio	1.55
Working Capital	$364.7M
Working Capital Turnover	$5.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.68%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-1.11%
200-day SMA	23.04
3Y total return	-20.73%
50-day SMA	22.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-28.98%
All Time High	50.77
All Time High Change	-54.58%
All Time High Date	2021-06-29
All Time Low	15.92
All Time Low Change	44.85%
All Time Low Date	2024-05-21
ATR	0.94
Beta	0.97
Beta1y	0.96
Beta2y	0.77
Ch YTD	-2.74
High	23.73
High52	26.51
High52 Date	2025-11-06
High52ch	-13.01%
Low	22.77
Low52	18.77
Low52 Date	2025-08-01
Low52ch	22.86%
Ma50ch	1.14%
Premarket Change Percent	0.04
Premarket Price	$24
Price vs 200-day SMA	0.08%
RSI	44.51
RSI Monthly	49.97
RSI Weekly	50.1
Sharpe ratio	0.01x
Sortino ratio	0.2
Total Return	-2.68%
Tr YTD	-2.74
Tr1m	3.04%
Tr1w	-7.2%
Tr3m	4.87%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	12
Analyst Count Top	1
Analyst Price Target Top	$30
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$0.22
Earnings EPS Estimate Growth	37.5
Earnings Revenue Estimate	561,535,136x
Earnings Revenue Estimate Growth	16.96x
Operating Income	$36.4M
Operating Income Growth	70.46
Operating Income Growth Q	42.24
Operating Income Growth5 Y	6.34
Operating margin	1.62
Price target	$31.08
Price Target Change	$34.78
Price Target Change Top	$30.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	113,145,384%
Float Percent	89.79%
Shares Insiders	0.6%
Shares Institutions	88.1%
Shares Out	126,012,374
Shares Qo Q	0.39%
Shares Yo Y	2.68%
Short Float	2.39%
Short Ratio	3.11
Short Shares	2.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$62.8M
Average Volume	982,329.55x
Bv Per Share	5.99
Ch1m	3.04
Ch1w	-7.2
Ch1y	-1.11
Ch3m	4.87
Ch3y	-20.73
Ch5y	-28.98
Ch6m	-1.58
Change	-3.88%
Change From Open	-2.16
Close	23.99
Days Gap	-1.75
Depreciation Amortization	11,287,000
Dollar Volume	24,915,061.7
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$36.4M
EBITDA	$47.7M
EPS	$0.17
F Score	5
FCF	$138M
FCF EV Yield	5.53x
FCF Per Share	$1.1
Financing CF	-6,211,000
Fiscal Year End	December
Founded	2,007
Goodwill	209,842,000
Graham Number	4.78079
Graham Upside	-79.27
Income Tax	$17.7M
Investing CF	-181,596,000
Ipr	0.26
Iprfo	-23.13
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-27
Lynch Fair Value	$0.85
Lynch Upside	-96.32
Ma150	23.44
Ma150ch	-1.64%
Ma20	23.96
Ma20ch	-3.75%
Net CF	-49,807,000
Next Earnings Date	2026-08-06
Open	23.57
Optionable	Yes
P FCF Ratio	21.06
P OCF Ratio	21.06
Position In Range	30.21
Post Close	23.06
Postmarket Change Percent	1.91
Postmarket Price	$23.5
Ppne	8,691,000
Pre Close	23.99
Price Date	2026-05-08
Price EBITDA	$60.89
Ptbv Ratio	8.79
Relative Volume	1.1x
Revenue	2,246,592,000x
SBC By Revenue	3.35x
Share Based Comp	75,199,000
Tax By Revenue	0.79x
Tax Rate	39.27%
Tr6m	-1.58%
Us State	Virginia
Volume	1,080,445
Z Score	4.58

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PRVA pay a dividend?

Capital-return profile for this ticker.

Performance

PRVA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PRVA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+88.1%

Float: +89.8% of shares outstanding

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PRVA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.5

Neutral momentum band

Price vs 200-day MA

+0.1%

50/200-day relationship not available

Beta (5Y)

0.97

Moves roughly with the market

Sharpe ratio

0.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PRVA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PRVA stock rating?

Privia Health Group, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PRVA analysis?

The full report lives at /stocks/PRVA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PRVA?

The latest report frames PRVA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PRVA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.